Cachet Pharmaceuticals - Public Comps and Valuation Multiples

Cachet Pharmaceuticals Overview

About Cachet Pharmaceuticals

Cachet Pharmaceutical Co Ltd is a state-owned stock company. Its main business includes: Medicine supply to hospitals, wholesaling of biological products, medical instruments, and traditional Chinese medicines. The Company also involved in pharmaceutical logistics and retail pharmacy chain.

Founded

1997

HQ

Employees

n/a

Website

cachet.com.cn

Sectors

Pharmacies

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$601M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Cachet Pharmaceuticals Financials

Cachet Pharmaceuticals has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Cachet Pharmaceuticals achieved revenue of $4.1B and an EBITDA of $126M.

Cachet Pharmaceuticals expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Cachet Pharmaceuticals valuation multiples based on analyst estimates

Cachet Pharmaceuticals P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$4.1B	n/a	XXX	XXX	XXX
Gross Profit	$295M	$290M	XXX	XXX	XXX
Gross Margin	7%	NaN%	XXX	XXX	XXX
EBITDA	$126M	n/a	XXX	XXX	XXX
EBITDA Margin	3%	NaN%	XXX	XXX	XXX
Net Profit	$48.8M	$40.9M	XXX	XXX	XXX
Net Margin	1%	NaN%	XXX	XXX	XXX
Net Debt	$190M	$253M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Cachet Pharmaceuticals Stock Performance

As of April 15, 2025, Cachet Pharmaceuticals's stock price is CNY 12 (or $2).

Cachet Pharmaceuticals has current market cap of CNY 3.6B (or $489M), and EV of CNY 4.4B (or $601M).

See Cachet Pharmaceuticals trading valuation data

Cachet Pharmaceuticals Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$601M	$489M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Cachet Pharmaceuticals Valuation Multiples

As of April 15, 2025, Cachet Pharmaceuticals has market cap of $489M and EV of $601M.

Cachet Pharmaceuticals's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Cachet Pharmaceuticals's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for Cachet Pharmaceuticals and 10K+ public comps

Cachet Pharmaceuticals Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$601M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	XXX	XXX
P/E	n/a	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	n/a	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Cachet Pharmaceuticals Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Cachet Pharmaceuticals Valuation Multiples

Cachet Pharmaceuticals's NTM/LTM revenue growth is n/a

Cachet Pharmaceuticals's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, Cachet Pharmaceuticals's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate Cachet Pharmaceuticals's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for Cachet Pharmaceuticals and other 10K+ public comps

Cachet Pharmaceuticals Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	n/a	XXX	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	n/a	XXX	XXX	XXX	XXX
Revenue per Employee	n/a	XXX	XXX	XXX	XXX
Opex per Employee	n/a	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	1%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	0%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	4%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry